Skip to main content
Fig. 1 | Cancer Cell International

Fig. 1

From: MiR-924 as a tumor suppressor inhibits non-small cell lung cancer by inhibiting RHBDD1/Wnt/β-catenin signaling pathway

Fig. 1

Decreased miR-924 expression in NSCLC tissues and cell lines. a Quantitative real time PCR was used to determine the expression profile of miR-924 in NSCLC tissues and adjacent tissues from 79 patients. NSCLC patients with metastasis (b) or advanced TNM stage (c) had lower miR-924 expression levels compared with those of non-metastatic or early TNM stage. The miR-665 expression level was assessed in four NSCLC cell lines (95D, H1299, A549 and H520) and normal human bronchial epithelial cell line BEAS-2B. **p < 0.01, ***p < 0.001, compared with BEAS-2B

Back to article page